Who is sponsoring NCT07115524?

NCT07115524 is sponsored by Assiut University.

What condition does NCT07115524 study?

NCT07115524 studies AssessIUS Scores inUC Versus Colonoscopy.

Is NCT07115524 still recruiting?

NCT07115524 is currently not yet recruiting. Last updated 13 January 2026.

Last reviewed 2026-01-13 · How we verify

NCT07115524: IUS/IBD

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Comparative Accuracy of Activity Scores of Intestinal Ultrasound and Colonoscopy in Monitoring Ulcerative Colitis Activity

Not yet recruiting Last updated 13 January 2026

What this trial tests

trial in AssessIUS Scores inUC Versus Colonoscopy in 200 participants. Not yet recruiting.

Timeline

1 September 2026

Primary endpoint
1 September 2026

1 September 2027

Quick facts

Lead sponsor	Assiut University
Status	Not yet recruiting
Study type	OBSERVATIONAL
Enrollment	200
Start date	1 September 2026
Primary completion	1 September 2026
Estimated completion	1 September 2027

Conditions studied

AssessIUS Scores inUC Versus Colonoscopy — all drugs for AssessIUS Scores inUC Versus Colonoscopy →

Sponsor

Assiut University

Who can join

Adults 18 to 60, any sex, with AssessIUS Scores inUC Versus Colonoscopy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Our study aimed to assess simple sonographic activity scores and Colonoscopy for active UC patients

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Assiut University trials

Trials by the same sponsor.

NCT07423312 — Lead Exposure and Multiple Sclerosis · not yet recruiting
NCT07234526 — Usage of Glucose Fluctuations as a Prognostic Marker in Septic Shock Patients · not yet recruiting
NCT07273214 — Knowledge, Attitude and Practice of Third Trimester Pregnant Mothers Towards Self-Medication in Assiut, Egypt · not yet recruiting
NCT07194863 — Efficacy of Essential Phospholipid Versus Betaine HCL/L-Glutamic Acid in MAFLD · not yet recruiting
NCT07053709 — Screening for Hyperuricemia in Patients With Metabolic Associated Fatty Liver Disease (MAFLD) · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT07115524 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Assiut University
Last refreshed: 13 January 2026

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07115524.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing